$12B
$705,000
0.06% of portfolio
3,080
Q1 2019
New
$0
$766,000
0.06% of portfolio
8,935
Q3 2024
Added 1.25%
$218B
$681,000
0.06% of portfolio
2,237
Q2 2024
Reduced 66.8%
$0
$556,000
0.05% of portfolio
4,502
Q4 2021
New
$7.91B
$559,000
0.05% of portfolio
5,157
Q1 2024
New
$142B
$602,000
0.05% of portfolio
1,869
Q3 2024
Added 73.22%
$1.64B
$610,000
0.05% of portfolio
6,379
Q2 2022
Reduced 0.78%
$160B
$577,000
0.05% of portfolio
2,133
Q2 2024
Reduced 0.05%
$506B
$582,000
0.05% of portfolio
1,179
Q2 2024
Added 3.79%
$0
$426,000
0.04% of portfolio
5,466
Q4 2022
New
$30.5B
$466,000
0.04% of portfolio
1,605
Q1 2024
Added 60.5%
$0
$439,000
0.04% of portfolio
3,761
Q2 2024
Reduced 0.69%
$60.2B
$533,000
0.04% of portfolio
1,560
Q3 2024
Added 30.0%
$740B
$487,000
0.04% of portfolio
550
Q3 2024
Added 35.14%
$259B
$486,000
0.04% of portfolio
6,023
Q3 2024
Reduced 14.24%
$699B
$522,000
0.04% of portfolio
2,480
Q2 2024
Added 11.31%
$91.1B
$397,000
0.03% of portfolio
194
Q3 2024
Added 6.59%
$78B
$373,000
0.03% of portfolio
3,600
Q3 2021
Reduced 1.72%
$454B
$399,000
0.03% of portfolio
684
Q3 2024
Reduced 25.57%
$29.9B
$397,000
0.03% of portfolio
4,131
Q3 2024
Added 7.86%
$0
$373,000
0.03% of portfolio
707
Q2 2024
New
$5.16B
$424,000
0.03% of portfolio
11,686
Q3 2024
Reduced 8.39%
$125B
$379,000
0.03% of portfolio
3,606
Q1 2024
Added 63.02%
$7.04B
$323,000
0.03% of portfolio
10,905
Q3 2024
New
$1.52T
$348,000
0.03% of portfolio
1,332
Q3 2024
Reduced 2.2%
$198B
$333,000
0.03% of portfolio
852
Q2 2024
Added 14.52%
$0
$421,000
0.03% of portfolio
4,146
Q3 2024
Added 10.38%
$0
$228,000
0.02% of portfolio
9,325
Q2 2024
New
$142B
$207,000
0.02% of portfolio
2,590
Q3 2024
New
$57.8B
$275,000
0.02% of portfolio
586
Q1 2024
Added 0.17%
$1.43B
$230,000
0.02% of portfolio
7,750
Q2 2024
New
$171B
$261,000
0.02% of portfolio
5,821
Q3 2024
Reduced 8.85%
$14.6B
$294,000
0.02% of portfolio
10,373
Q3 2024
Reduced 0.92%
$23.6B
$296,000
0.02% of portfolio
692
Q2 2023
New
$0
$211,000
0.02% of portfolio
433
Q3 2024
Reduced 46.41%
$70.8B
$277,000
0.02% of portfolio
2,028
Q3 2024
Reduced 25.71%
$57.1B
$234,000
0.02% of portfolio
1,000
Q1 2024
New
$173B
$290,000
0.02% of portfolio
2,395
Q1 2024
New
$129B
$227,000
0.02% of portfolio
390
Q3 2024
New
$207B
$232,000
0.02% of portfolio
376
Q1 2024
Reduced 3.84%
$97B
$243,000
0.02% of portfolio
4,762
Q3 2024
Added 0.04%
$0
$218,000
0.02% of portfolio
5,340
Q3 2024
New
$195B
$263,000
0.02% of portfolio
2,170
Q2 2024
Reduced 58.49%
$0
$213,000
0.02% of portfolio
3,650
Q2 2024
New
$555M
$131,000
0.01% of portfolio
14,810
Q3 2024
Reduced 6.33%
Ge Healthcare Technologies
-
$0
0.0% of portfolio
-
Q3 2024
Added 7.63%
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 0.98%
Canadian Pacific Kansas City
-
$0
0.0% of portfolio
-
Q3 2024
Added 3.0%
-
$0
0.0% of portfolio
-
Q3 2024
Added 1.42%
T. Rowe Price Capital Appr Equity ETF
-
$0
0.0% of portfolio
-
Q3 2024
Added 12.59%